At the Spanish Health Economics Association (AES) conference in May 2011, OHE’s Ruth Puig Peiró discussed a recent OHE study that reviewed the available literature on variations in medicines’ efficacy and effectiveness across countries.

OHE has just released the publication of the presentation given by Prof Mike Richards at OHE's 16th Annual Lecture. National Clinical Director for Cancer and End of Life Care in England's Department of Health, Prof Richards addressed five questions about the NHS achieving world class outcomes in cancer.

Just released is the new OHE Guide to UK Health and Health Care Statistics, which provides both reliable up-to-date statistics and a basic guide to finding and using health statistics for the UK and, to some extent, other OECD countries.

OHE is making available as Occasional Papers drafts of two important chapters that will appear in the Oxford Handbook on the Economics of the Pharmaceutical Industry due out in 2012. One on access to drugs and vaccines in developing countries and the other on measuring value with pharmacoeconomics.

The 2011 OHE Annual Lecture -- Cost per QALY in the U.S. and Britain: Damned if You Do and Damned if You Don't? -- will be presented by Prof Milton Weinstein of Harvard University on 15 November 2011 in London. He will examine the differences in the US and British perspectives and argue for a convergence that combines the two approaches.